β¨ Medicines Distribution Consent
NEW ZEALAND GAZETTE, No. 57
16 MAY 2013
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Ibuprofen for Children
- Active Ingredient: Ibuprofen 20mg/mL
- Dosage Form: Oral suspension
- New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
- Manufacturer: Drug Houses of Australia Private Limited, Singapore
Product:
Lemsip For Pharmacy Sinus Day & Night
- Day Tablet:
- Active Ingredients: Paracetamol 500mg, Phenylephrine hydrochloride 5mg
- Dosage Form: Tablet
- Night Tablet:
- Active Ingredients: Chlorphenamine maleate 2mg, Paracetamol 500mg, Phenylephrine hydrochloride 5mg
- Dosage Form: Tablet
- New Zealand Sponsor: Reckitt Benckiser (New Zealand) Limited
- Manufacturer: PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand
Product:
Lemsip For Pharmacy Sinus Pain & Allergy
- Active Ingredients: Chlorphenamine maleate 2mg, Paracetamol 500mg, Phenylephrine hydrochloride 5mg
- Dosage Form: Tablet
- New Zealand Sponsor: Reckitt Benckiser (New Zealand) Limited
- Manufacturer: PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand
Product:
Lemsip For Pharmacy Cold & Flu
- Active Ingredients: Codeine phosphate hemihydrate 6mg, Paracetamol 500mg, Phenylephrine hydrochloride 5mg
- Dosage Form: Tablet
- New Zealand Sponsor: Reckitt Benckiser (New Zealand) Limited
- Manufacturer: PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand
Product:
Lemsip For Pharmacy Cold & Flu Day & Night
- Day Tablet:
- Active Ingredients: Codeine phosphate hemihydrate 6mg, Paracetamol 500mg, Phenylephrine hydrochloride 5mg
- Dosage Form: Tablet
- Night Tablet:
- Active Ingredients: Chlorphenamine maleate 2mg, Paracetamol 500mg, Phenylephrine hydrochloride 5mg
- Dosage Form: Tablet
- New Zealand Sponsor: Reckitt Benckiser (New Zealand) Limited
- Manufacturer: PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand
Dated this 9th day of May 2013.
DR MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
Next Page →
β¨ LLM interpretation of page content
π₯ Consent to Distribution of New Medicines
π₯ Health & Social Welfare9 May 2013
Medicines, Distribution Consent, Ibuprofen, Lemsip, Pharmaceuticals
- DR MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
NZ Gazette 2013, No 57